Delivery Order SPE2DB20D1100-SPE2DB25FA5K1

Award Date 2/10/25
Potential Completion Date 3/4/25
Potential Value $42K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of LYNPARZA 150 MG TABLET UU 120S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $21,135.20 fixed-price contract with AmerisourceBergen Drug Corp, a major pharmaceutical distributor, has a period of performance through January 24, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical for comprehensive pharmaceutical and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,519.62 firm fixed-price delivery order covers the procurement of 4567090102 ! LYNPARZA 100 MG TABLET UU 120S, with a period of performance through February 20, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award is for the delivery of LYNPARZA 150 MG TABLET in quantities of 120 per shipment. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The firm-fixed-price delivery order has a ceiling value of $118,261.86 and an ultimate completion date of October 9, 2024. This contract is not associated with a set-aside program. Amerisourcebergen holds a larger Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of LYNPARZA 150 MG TABLET UU 60S, a specialty pharmaceutical product. The contract has a firm fixed price of $39,098.88 and a completion date of January 24, 2024. It is a delivery order contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $31,702.80 firm-fixed-price contract is for the provision of LYNPARZA 150 MG TABLET medication, with a performance period through February 25, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This federal contract award, valued at $20,359.02, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Lynparza 100 mg tablets. The contract is a firm-fixed-price delivery order with a completion date of December 31, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,179.51 firm fixed-price delivery order is for the drug LYNPARZA 100 mg tablets. The contract has an ultimate completion date of January 15, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award is a delivery order valued at $21,039.24 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LYNPARZA 100 MG TABLET, a pharmaceutical product. The award has an ultimate completion date of February 27, 2025 and utilizes a firm fixed price pricing type. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $9,774.74 for the supply of LYNPARZA 150 MG TABLET. The contract has an ultimate completion date of October 31, 2024 and was awarded on October 9, 2024 by the Defense Logistics Agency (DLA), a defense agency. The contract is a firm fixed price arrangement and is not designated as a set-aside. Amerisourcebergen Drug Corp, the prime contractor, is a for-profit...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,271.84 firm-fixed-price delivery order contract is for the supply of the drug Lynparza 100 mg tablets. The award has an ultimate completion date of March 4, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FA5K1
    Delivery Order

This federal contract award is a delivery order for LYNPARZA 150 MG TABLET UU 120S, valued at $42,270.40, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract has a firm fixed price and an ultimate completion date of March 4, 2025.

AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, including the military and veterans' healthcare programs. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is not designated with a set-aside requirement, indicating open competition.

Generated 5/12/25, 10:05 AM